CLRB Cellectar Biosciences, Inc. - Common Stock
$2,60
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$2–$7
9% of range
Analystenbewertung
BUY
9 analysts
Kursziel
$12
+342% upside
P/E (TTM)
-0.4
ROE
—
Nettogewinnmarge
—
CLRB Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.60
Marktkapitalisierung
—
P/E (TTM)
-0.4
EPS (TTM)
$-8.35
Umsatz (TTM)
—
Dividendenrendite
—
ROE
—
Verschuldungsgrad
—
52W-Spanne
$2 – $7
CLRB Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-8.35
2022-12-31
→
2025-12-31
Freier Cashflow
—
2023-12-31
→
2024-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
CLRB
Peer-Median
P/E (TTM)
-0.4
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
CLRB
Peer-Median
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
CLRB
Peer-Median
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
CLRB
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
CLRB
Peer-Median
CLRB Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
9 Analysten
- Starker Kauf 3 33,3%
- Kauf 5 55,6%
- Halten 1 11,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
4 Analysten · 2026-08-14
Median
$10.50
Mittelwert
$11.50
← Unter allen Zielen
$2.60
Tief
$10.00
Hoch
$15.00
Median-Ziel
$10.50
+303,8%
Mittelwert-Ziel
$11.50
+342,3%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.85%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-1.30 | $-1.92 | 0.62% |
| 31. Dezember 2025 | $-1.29 | $-2.34 | 1.0% |
| 30. September 2025 | $-1.41 | $-2.58 | 1.2% |
| 30. Juni 2025 | $-3.39 | $-3.98 | 0.59% |
| 31. März 2025 | $-4.20 | $-5.00 | 0.80% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CLRB | — | -0.4 | — | — | — | — |
| JSPR | — | -0.5 | — | — | — | — |
| ALLR | $17M | -0.0 | — | -3509.7% | -102.1% | — |
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| HOWL | $31M | -0.5 | — | — | -183.6% | — |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | — |
| SKYE | $25M | -0.5 | — | — | -175.6% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $11M | $26M | $27M | $18M | $18M | $10M | $9M | $7M | $9M | $5M | $5M | $6M | |
| SG&A Expense | $11M | $26M | $12M | $11M | $7M | $5M | $5M | $5M | $4M | $5M | $3M | $4M | |
| Operating Expenses | $23M | $52M | $39M | $29M | $24M | $15M | $14M | $13M | $14M | $9M | $9M | $10M | |
| Operating Income | $-23M | $-52M | $-39M | $-29M | $-24M | $-15M | $-14M | $-13M | $-14M | $-9M | $-9M | $-10M | |
| Other Non-op | $1M | $7M | $-4M | $-3M | $8.9K | $196.2K | $85.7K | $91.7K | $38.7K | $3M | $3M | $2M | |
| Pretax Income | $-22M | $-45M | $-43M | $-32M | $-24M | · | · | · | · | · | · | · | |
| Income Tax | · | $66.0K | $-60.0K | $-60.0K | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-22M | $-45M | $-43M | $-32M | $-24M | $-15M | $-14M | $-13M | $-14M | $-6M | $-5M | $-8M | |
| EPS (Basic) | $-8.35 | $-36.52 | $-3.50 | $-4.51 | $-4.35 | $-0.76 | · | · | · | · | · | · | |
| EPS (Diluted) | $-8.35 | $-41.89 | $-3.50 | $-4.51 | $-4.35 | $-1.84 | · | · | · | · | · | · | |
| Shares (Basic) | 2,608,317 | 1,220,749 | 12,221,571 | 7,055,665 | 5,551,572 | 19,812,659 | · | · | · | · | · | · | |
| Shares (Diluted) | 2,608,317 | 1,238,125 | 12,221,571 | 7,055,665 | 5,551,572 | 19,812,659 | · | · | · | · | · | · | |
| EBITDA | · | $-51M | $-39M | · | $-24M | · | $-14M | $-13M | $-12M | $-9M | $-8M | $-10M |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $23M | $10M | $20M | $36M | $57M | $11M | $13M | $10M | $11M | $4M | $9M | |
| Prepaid Expense | $842.4K | $961.7K | $888.2K | $663.2K | $867.5K | $774.4K | $771.0K | $641.2K | $412.2K | $693.6K | $267.8K | $220.6K | |
| Current Assets | $14M | $24M | $10M | $21M | $37M | $58M | $11M | $14M | $10M | $12M | $4M | $10M | |
| PP&E (Net) | $549.4K | $757.1K | $1M | $418.6K | $344.5K | $356.0K | $435.1K | $543.3K | $244.7K | $1M | $2M | $2M | |
| PP&E (Gross) | · | · | $2M | $1M | $889.3K | $759.7K | $744.5K | $724.5K | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $1M | $1M | $885.0K | $692.5K | $544.8K | $403.7K | $309.4K | $181.2K | $6M | $4M | $4M | $4M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $29.8K | $29.8K | $29.8K | $81.2K | $6.2K | $6.2K | $6.2K | $18.1K | $11.9K | $11.9K | $11.9K | $11.9K | |
| Total Assets | $15M | $25M | $12M | $22M | $37M | $59M | $12M | $15M | $13M | $15M | $8M | $13M | |
| Accounts Payable | $4M | $4M | $6M | $3M | $1M | $1M | $1M | $612.0K | $933.0K | $1M | $675.9K | $934.0K | |
| Short-term Debt | · | · | · | · | · | · | · | · | $0 | $86.6K | $243.6K | $119.9K | |
| Current Liabilities | $5M | $9M | $25M | $12M | $4M | $4M | $3M | $2M | $2M | $2M | $6M | $6M | |
| Capital Leases | $309.4K | $409.6K | $494.0K | $553.0K | $166.3K | $301.7K | $421.6K | $0 | $2.2K | $5.2K | $8.0K | $11.1K | |
| Total Liabilities | $5M | $10M | $26M | $12M | $4M | $4M | $3M | $2M | $2M | $2M | $6M | $7M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $330.2K | $450.0K | |
| Total Debt | · | · | · | · | · | · | · | · | $0 | $86.6K | $243.6K | · | |
| Common Stock | $42 | $15 | $207 | $94 | $61 | $454 | $94 | $47 | $16 | $104 | $9 | $8 | |
| Paid-in Capital | $277M | $261M | $183M | $168M | $183M | $162M | $120M | $108M | $94M | $83M | $66M | $66M | |
| Retained Earnings | $-269M | $-247M | $-203M | $-160M | $-151M | $-127M | $-112M | $-98M | $-84M | $-71M | $-65M | $-59M | |
| Stockholders' Equity | $9M | $14M | $-15M | $8M | $29M | $55M | $9M | $13M | $11M | $14M | $2M | $7M | |
| Liabilities + Equity | $15M | $25M | $12M | $22M | $37M | $59M | $12M | $15M | $13M | $15M | $8M | $13M | |
| Shares Outstanding | 4,240,129 | 1,535,996 | 20,744,110 | 9,385,272 | 6,110,125 | 45,442,729 | 9,386,689 | 4,732,387 | 1,666,144 | 10,368,325 | 858,140 | 756,276 |
Cashflow 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $213.6K | $291.7K | $192.4K | $148.4K | $149.9K | $141.5K | $132.8K | $82.3K | $2M | $356.7K | $362.5K | $367.2K | |
| Stock-based Comp | $2M | $4M | $2M | $1M | $1M | $467.5K | $866.8K | $721.2K | $758.8K | $529.2K | $447.3K | $850.4K | |
| Deferred Tax | $-7M | $-20M | $-15M | $-10M | $-8M | $-5M | $-8M | $-3M | $16M | $-4M | $-3M | $-3M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $204.0K | · | |
| Other Non-cash | · | $12M | $23M | · | · | · | $10M | $4M | $-15M | $965.5K | $-464.7K | $1M | |
| Operating Cash Flow | $-23M | $-48M | $-32M | $-25M | $-23M | $-14M | $-12M | $-11M | $-11M | $-8M | $-8M | $-9M | |
| CapEx | $5.9K | $104.2K | $864.0K | $226.0K | $141.4K | $62.4K | $24.5K | $385.0K | $346.7K | $72.3K | $58.5K | $29.6K | |
| Investing Cash Flow | $-5.9K | $-104.2K | $-864.0K | $-226.0K | $-141.4K | $-62.4K | $-24.5K | $-330.0K | $-346.7K | $-72.3K | · | · | |
| Debt Issued | · | · | · | · | · | $184.0K | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | $-86.6K | $-243.6K | $-119.8K | · | |
| Stock Issued | · | · | · | $10M | $34.9K | $60M | $9M | $9M | $5M | $12M | $3M | $12M | |
| Net Stock Activity | · | · | · | · | $34.9K | · | $9M | $9M | $5M | $12M | $3M | $12M | |
| Financing Cash Flow | $13M | $61M | $23M | $10M | $1M | $61M | $9M | $15M | $10M | $16M | · | · | |
| Net Change in Cash | $-10M | $14M | $-10M | $-16M | $-21M | $47M | $-3M | $3M | $-1M | $8M | $-6M | $7M | |
| Free Cash Flow | · | $-48M | $-33M | · | $-23M | · | $-12M | $-12M | $-11M | $-8M | $-8M | $-9M |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -237.4% | · | · | -50.3% | · | -103.2% | -94.8% | -96.2% | -53.9% | -52.3% | · | |
| ROE | · | -302.7% | · | · | -67.3% | · | -132.4% | -87.8% | -147.8% | -81.4% | -131.7% | · | |
| ROIC | · | -362.8% | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.6 | · | · | 9.2 | · | 4.1 | 8.6 | 5.2 | 7.5 | 0.7 | · | |
| Quick Ratio | · | 2.5 | · | · | 8.9 | · | 3.8 | 8.2 | 4.7 | 7.0 | 0.7 | · | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.1 | · |
Bewertung (TTM) 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-22M | $-45M | $-43M | $-32M | $-24M | $-15M | $-14M | $-13M | $-14M | $-6M | $-5M | $-8M | |
| Market Cap | · | $415M | · | · | $12.10B | · | $6.34B | $2.20B | $68.48B | $3.14B | $19.05B | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | $68.47B | $3.13B | $19.05B | · | |
| P/E | -0.4 | -0.2 | -23.7 | -11.4 | -45.5 | -339.1 | · | · | · | · | · | · | |
| P/B | · | 29.0 | · | · | 366.1 | · | 699.4 | 165.9 | 6367.5 | 232.0 | 11547.3 | · | |
| P / Tangible Book | 1.5 | 29.0 | · | 59.1 | 416.3 | 517.5 | · | · | · | · | · | · | |
| P / Cash Flow | · | -8.7 | · | · | -536.1 | · | -541.8 | -192.3 | -6213.9 | -379.2 | -2319.6 | · | |
| P / FCF | · | -8.7 | · | · | -532.7 | · | -540.7 | -186.1 | -6024.3 | -375.9 | -2303.2 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | -5679.7 | -344.2 | -2268.8 | · | |
| EV / FCF | · | · | · | · | · | · | · | · | -6023.4 | -374.6 | -2302.8 | · | |
| Earnings Yield | -283.0% | -465.4% | -4.2% | -8.8% | -2.2% | -0.29% | · | · | · | · | · | · |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $5M | $3M | $3M | $3M | $2M | $3M | $6M | $5M | $7M | $7M | $8M | $7M | $6M | $6M | $4M | $5M | |
| SG&A Expense | $3M | $3M | $3M | $2M | $4M | $3M | $7M | $8M | $6M | $5M | $5M | $2M | $2M | $2M | $3M | $3M | |
| Operating Expenses | $7M | $6M | $6M | $5M | $6M | $6M | $13M | $13M | $14M | $12M | $13M | $9M | $8M | $9M | $7M | $8M | |
| Operating Income | $-7M | $-6M | $-6M | $-5M | $-6M | $-6M | $-13M | $-13M | $-14M | $-12M | $-13M | $-9M | $-8M | $-9M | $-7M | $-8M | |
| Other Non-op | $265.4K | $140.0K | $395.4K | $406.8K | $589.6K | $-203.0K | $10M | $-1M | $13M | $-15M | $5M | $-8M | $-2M | $2M | $-3M | $304.2K | |
| Net Income | $-7M | $-6M | $-5M | $-4M | $-5M | $-7M | $-2M | $-15M | $-919.4K | $-27M | $-8M | $-18M | $-10M | $-7M | $-10M | $-8M | |
| EPS (Basic) | $-0.57 | $-1.33 | $-3.41 | $-1.41 | $-3.39 | $-4.30 | $-23.66 | $-11.18 | $-0.77 | $-0.91 | $-0.41 | $-1.55 | $-0.90 | $-0.64 | $-1.01 | $-1.23 | |
| EPS (Diluted) | $-0.57 | $-1.33 | $-3.41 | $-1.41 | $-3.39 | $-4.30 | $-23.42 | $-12.13 | $-5.43 | $-0.91 | $-0.41 | $-1.55 | $-0.90 | $-0.64 | $-1.01 | $-1.23 | |
| Shares (Basic) | 12,231,851 | 4,240,129 | -48,242,397 | 3,162,040 | 1,608,799 | 1,535,995 | -30,631,108 | 1,311,197 | 1,193,981 | 29,346,679 | -21,609,601 | 11,308,738 | 11,261,217 | 11,261,217 | -11,274,703 | 6,110,119 | |
| Shares (Diluted) | 12,231,851 | 4,240,129 | -48,242,397 | 3,162,040 | 1,608,799 | 1,535,995 | -30,683,238 | 1,326,474 | 1,248,210 | 29,346,679 | -21,609,601 | 11,308,738 | 11,261,217 | 11,261,217 | -11,274,703 | 6,110,119 | |
| EBITDA | $-7M | $-6M | · | $-5M | $-6M | $-6M | · | $-13M | $-14M | $-12M | · | $-9M | $-8M | $-9M | · | $-8M |
Bilanz 18
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $8M | $13M | $13M | $11M | $14M | $23M | $34M | $26M | $40M | $10M | $19M | $5M | $13M | $20M | $18M | |
| Prepaid Expense | $883.7K | $920.0K | $842.4K | $1M | $2M | $987.5K | $961.7K | $2M | $2M | $1M | $888.2K | $1M | $456.7K | $1M | $663.2K | $975.9K | |
| Current Assets | $35M | $9M | $14M | $14M | $13M | $15M | $24M | $36M | $28M | $41M | $10M | $20M | $6M | $14M | $21M | $19M | |
| PP&E (Net) | $304.2K | $339.7K | $549.4K | $595.3K | $647.5K | $700.8K | $757.1K | $910.1K | $978.7K | $1M | $1M | $893.5K | $337.4K | $376.1K | $418.6K | $338.9K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $885.0K | · | · | · | $692.5K | · | |
| Other Non-current Assets | $23.6K | $29.8K | $29.8K | $29.8K | $29.8K | $29.8K | $29.8K | $29.8K | $29.8K | $29.8K | $29.8K | $6.2K | $6.2K | $6.2K | $81.2K | · | |
| Total Assets | $37M | $11M | $15M | $15M | $14M | $16M | $25M | $37M | $29M | $43M | $12M | $22M | $7M | $15M | $22M | $19M | |
| Accounts Payable | $5M | $5M | $1M | $4M | $5M | $4M | $4M | $8M | $6M | $7M | $6M | $8M | $6M | $7M | $3M | $6M | |
| Current Liabilities | $5M | $5M | $5M | $5M | $6M | $6M | $9M | $20M | $15M | $29M | $25M | $16M | $6M | $7M | $12M | $7M | |
| Capital Leases | $2M | $2M | $309.4K | $335.9K | $361.5K | $386.2K | $409.6K | $431.9K | $453.5K | $474.3K | $494.0K | $512.8K | $530.9K | $548.3K | $553.0K | $53.8K | |
| Total Liabilities | $7M | $6M | $5M | $5M | $6M | $6M | $10M | $21M | $16M | $29M | $26M | $17M | $7M | $8M | $12M | $7M | |
| Common Stock | $83 | $42 | $42 | $32 | $18 | $461 | $15 | $406 | $358 | $332 | $207 | $99 | $97 | $97 | $94 | $61 | |
| Paid-in Capital | $312M | $278M | $277M | $271M | $265M | $262M | $261M | $247M | $235M | $225M | $183M | $195M | $194M | $194M | $168M | $184M | |
| Retained Earnings | $-282M | $-275M | $-269M | $-264M | $-259M | $-254M | $-247M | $-245M | $-230M | $-229M | $-203M | $-210M | $-196M | · | $-160M | $-172M | |
| Stockholders' Equity | $30M | $3M | $9M | $8M | $6M | $8M | $14M | $15M | $12M | $13M | $-15M | $-13M | $-467.0K | $7M | $8M | $13M | |
| Liabilities + Equity | $37M | $11M | $15M | $15M | $14M | $16M | $25M | $37M | $29M | $43M | $12M | $22M | $7M | $15M | $22M | $19M | |
| Shares Outstanding | 8,252,108 | 4,240,129 | 4,240,129 | 3,192,040 | 1,812,040 | 46,079,875 | 1,535,996 | 40,566,534 | 35,848,924 | 33,164,466 | 20,744,110 | 9,918,384 | 9,740,507 | 9,740,507 | 9,385,272 | 6,110,119 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $49.5K | $52.3K | $55.6K | $56.3K | $68.6K | $68.6K | $66.0K | $88.5K | $70.0K | $41.2K | $38.6K | $42.6K | $38.2K | $33.0K | |
| Stock-based Comp | $428.3K | $451.9K | $567.8K | $567.8K | $565.4K | $562.7K | $1M | $2M | $799.2K | $454.4K | $1M | $497.9K | $419.8K | $408.2K | $361.4K | $367.8K | |
| Other Non-cash | · | · | · | · | · | $-3M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-6M | $-5M | $-4M | $-4M | $-5M | $-9M | $-11M | $-9M | $-14M | $-13M | $-10M | $-8M | $-8M | $-7M | $-7M | $-7M | |
| CapEx | $0 | $3.4K | · | · | · | · | $61.3K | $0 | $21.3K | $21.6K | $266.8K | · | · | · | $117.9K | $7.1K | |
| Investing Cash Flow | $0 | $-3.4K | · | · | · | · | $-61.3K | $0 | $-21.3K | $-21.6K | $-266.8K | · | · | · | $-117.9K | $-7.1K | |
| Financing Cash Flow | · | · | $5M | $6M | · | · | $0 | $18M | $1 | $44M | $441.0K | $22M | $0 | $3 | · | · | |
| Net Change in Cash | $26M | $-5M | $641.7K | $2M | $-3M | $-9M | $-11M | $8M | $-14M | $30M | $-9M | $14M | $-8M | $-7M | $2M | $-7M | |
| Free Cash Flow | · | $-5M | · | · | · | · | · | · | · | $-13M | · | · | · | · | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -27.5% | -41.6% | · | -17.1% | -25.3% | -22.4% | · | -49.8% | -5.1% | · | · | -67.2% | -50.7% | · | · | -25.5% | |
| ROE | -38.6% | -97.6% | · | -38.4% | -59.0% | -63.6% | · | -1618.5% | -15.4% | · | · | 4559.8% | -83.4% | · | · | -30.4% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 1.9 | · | 2.8 | 2.2 | 2.5 | · | 1.8 | 1.8 | 1.4 | · | 1.2 | 0.9 | 2.0 | · | 2.9 | |
| Quick Ratio | 6.5 | 1.7 | · | 2.6 | 1.9 | 2.3 | · | 1.7 | 1.7 | 1.4 | · | 1.2 | 0.8 | 1.8 | · | 2.7 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-22M | $-22M | · | $-31M | $-28M | $-49M | · | $-60M | $-55M | $-62M | · | $-42M | $-31M | $-27M | · | $-25M | |
| Market Cap | $23M | $11M | · | $18M | $13M | $442M | · | $2.60B | $2.69B | $3.96B | · | $786M | $570M | $418M | · | $616M | |
| P/E | -0.4 | -0.2 | · | -0.3 | -0.3 | -0.5 | · | -3.2 | -8.5 | -29.9 | · | -18.3 | -15.9 | -11.3 | · | -24.3 | |
| P/B | 0.8 | 3.2 | · | 2.2 | 2.1 | 53.6 | · | 171.7 | 217.2 | 316.8 | · | -58.8 | -1220.2 | 57.0 | · | 48.3 | |
| P / Tangible Book | 0.8 | 3.2 | · | 2.2 | 2.1 | 53.6 | · | 171.7 | 217.2 | 316.8 | · | · | · | 57.0 | · | 48.3 | |
| P / Cash Flow | · | -2.2 | · | · | · | -47.1 | · | · | · | -296.4 | · | · | · | -58.2 | · | · | |
| P / FCF | · | -2.2 | · | · | · | · | · | · | · | -295.9 | · | · | · | · | · | · | |
| Earnings Yield | -241.0% | -410.6% | · | -304.8% | -296.6% | -193.8% | · | -31.2% | -11.7% | -3.4% | · | -5.5% | -6.3% | -8.9% | · | -4.1% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-22M | $-45M | $-43M | — | — |
| Verwässerte EPS | $-8.35 | $-41.89 | $-3.50 | — | — |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | — | 2.6 | — | — | — |
| Quick Ratio | — | 2.5 | — | — | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | $-48M | $-33M | — | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 29 Einreicher · $8.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 15 (+14 vs. Vorquartal) | 3 (0 vs. Vorquartal) | 4 (+3 vs. Vorquartal) | 1 (-3 vs. Vorquartal) | +2.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Caligan Partners LP | $1.306.594 | 469.998 | 15,82% | Aktien |
| STEMPOINT CAPITAL LP | $986.728 | 354.938 | 11,95% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $910.080 | 327.367 | 11,02% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $894.404 | 321.728 | 10,83% | Aktien |
| Bleichroeder LP | $802.528 | 288.679 | 9,72% | Aktien |
| Balyasny Asset Management L.P. | $611.600 | 220.000 | 7,40% | Aktien |
| Nantahala Capital Management, LLC | $611.594 | 219.998 | 7,40% | Aktien |
| Empery Asset Management, LP | $527.102 | 189.605 | 6,38% | Aktien |
| DIADEMA PARTNERS LP | $384.588 | 138.341 | 4,66% | Aktien |
| Stonepine Capital Management, LLC | $290.649 | 104.550 | 3,52% | Aktien |
| Persistent Asset Partners Ltd | $258.493 | 92.983 | 3,13% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $236.492 | 85.069 | 2,86% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $139.864 | 50.308 | 1,69% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $128.492 | 46.220 | 1,56% | Aktien |
| Sequoia Financial Advisors, LLC | $60.743 | 21.850 | 0,74% | Aktien |
| Riverview Capital Advisers, LLC | $50.051 | 10.384 | 0,61% | Aktien |
| NORTHERN TRUST CORP | $41.252 | 14.839 | 0,50% | Aktien |
| BlackRock, Inc. | $13.163 | 4.735 | 0,16% | Aktien |
| VANGUARD GROUP INC | $1.661 | 563 | 0,02% | Aktien |
| BARCLAYS PLC | $1.560 | 561 | 0,02% | Aktien |
| MORGAN STANLEY | $1.418 | 510 | 0,02% | Aktien |
| TD Waterhouse Canada Inc. | $178 | 63 | 0,00% | Aktien |
| UBS Group AG | $92 | 33 | 0,00% | Aktien |
| ACADIAN ASSET MANAGEMENT LLC | $46 | 16.577 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $31 | 11 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $18 | 7 | 0,00% | Aktien |
| US BANCORP \DE\ | $8 | 3 | 0,00% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $8 | 3 | 0,00% | Aktien |
| DANSKE BANK A/S | $6 | 2 | 0,00% | Aktien |
Unternehmensinsider 22 Insider · 12 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| James V Caruso | President & CEO | 7. Juli 2026 A | 20.318 | 2 | 0 | $25.258 |
| Simon Pedder | President and CEO | 20. August 2014 P | 13.300 | 0 | 0 | $0 |
| Chad J Kolean | CFO | 7. Juli 2026 A | 6.418 | 0 | 0 | $0 |
| Brian M Posner | Chief Financial Officer | 17. Januar 2019 A | — | 0 | 0 | $0 |
| Jarrod Longcor | Chief Operating Officer | 7. Juli 2026 A | 20.451 | 2 | 0 | $25.258 |
| Andrei Shustov | Senior Vice President, Medical | 14. Juni 2024 A | 55.038 | 0 | 0 | $0 |
| Darrell Shane Lea | Chief Commercial Officer | 14. Juni 2024 A | 39.599 | 0 | 0 | $0 |
| John E. Friend II | Chief Medical Officer | 4. März 2021 A | 100.000 | 0 | 0 | $0 |
| Igor D Grachev | Chief Medical Officer | 6. Januar 2020 A | — | 0 | 0 | $0 |
| Jamey P Weichert | Chief Scientific Officer | 12. Mai 2016 A | — | 0 | 0 | $0 |
| John Patrick Genn | VP of Business Development | 26. Februar 2015 A | — | 0 | 0 | $0 |
| Cameron Szakacs | VP of Clinical Development | 24. November 2014 A | — | 0 | 0 | $0 |
| Andrew Gu | Direktor | 7. Juli 2026 A | — | 0 | 0 | $0 |
| Asher Chanan-Khan | Direktor | 7. Juli 2026 A | — | 0 | 0 | $0 |
| Douglas J Swirsky | Direktor | 7. Juli 2026 A | 25.000 | 0 | 0 | $0 |
| John Neis | Direktor | 7. Juli 2026 A | 10 | 0 | 1 | $-733 |
| Frederick W Driscoll | Direktor | 7. Juli 2026 A | 19.417 | 0 | 0 | $0 |
| Stephen A Hill | Direktor | 24. Juni 2020 A | 18.000 | 0 | 0 | $0 |
| Paul L Berns | Direktor | 20. April 2016 P | 117.371 | 0 | 0 | $0 |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10%-Eigentümer | 8. September 2014 P | 1.142.368 | 0 | 0 | $0 |
| Stefan Loren | — | 8. Juli 2026 A | — | 0 | 0 | $0 |
| Dov Elefant | — | 25. Januar 2022 A | 11.755 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Wisconsin Alumni Research Foundation 2) ×2 Einreichungen | 2. Dezember 2016 | — | Erste Einreichung | Passive Anlage | SEC |
| Austin W. Marxe, David M. Greenhouse, Adam Stettner (2) | 29. Januar 2015 | — | Erste Einreichung | Passive Anlage | SEC |
| Austin W. Marxe, David M. Greenhouse and Adam C. Stettner | 9. September 2014 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.